Try our beta test site
1 study found for:    CP20-0903
Show Display Options
Rank Status Study
1 Active, not recruiting Study of IMC-18F1 or Ramucirumab DP in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
Condition: Breast Cancer
Interventions: Biological: Ramucirumab DP;   Biological: IMC-18F1;   Drug: Capecitabine

Study has passed its completion date and status has not been verified in more than two years.